第一单位：
Gene Center, Laboratory for Translational Cancer Immunology, Ludwig-Maximilians-Universität München, Munich, Germany.;Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.
作者：
Bettina,Brauchle [1]
;
Rebecca L,Goldstein [2]
;
Christine M,Karbowski [3]
;
Anja,Henn [4]
;
Chi-Ming,Li [2]
;
Veit L,Bücklein [1]
;
Christina,Krupka [1]
;
Michael C,Boyle [3]
;
Priya,Koppikar [3]
;
Sascha,Haubner [1]
;
Joachim,Wahl [4]
;
Christoph,Dahlhoff [4]
;
Tobias,Raum [4]
;
Matthew J,Rardin [2]
;
Christine,Sastri [2]
;
Dan A,Rock [2]
;
Michael,von Bergwelt-Baildon [5]
;
Brendon,Frank [2]
;
Klaus H,Metzeler [6]
;
Ryan,Case [2]
;
Matthias,Friedrich [4]
;
Mercedesz,Balazs [2]
;
Karsten,Spiekermann [7]
;
Angela,Coxon [4]
;
Marion,Subklewe [8]
;
Tara,Arvedson [9]
作者单位：
Gene Center, Laboratory for Translational Cancer Immunology, Ludwig-Maximilians-Universität München, Munich, Germany.;Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.
[1]
Amgen Research, Amgen Inc., South San Francisco, California.
[2]
Amgen Research, Amgen Inc., Thousand Oaks, California.
[3]
Amgen Research Munich GmbH, Munich, Germany.
[4]
Gene Center, Laboratory for Translational Cancer Immunology, Ludwig-Maximilians-Universität München, Munich, Germany.;Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.;German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
[5]
Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.;German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
[6]
Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.;German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.;Experimental Leukemia and Lymphoma Research (ELLF), Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.
[7]
Gene Center, Laboratory for Translational Cancer Immunology, Ludwig-Maximilians-Universität München, Munich, Germany. taraa@amgen.com marion.subklewe@med.uni-muenchen.de.;Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.;German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
[8]
Amgen Research, Amgen Inc., South San Francisco, California. taraa@amgen.com marion.subklewe@med.uni-muenchen.de.
[9]
主题词
动物(Animals);抗体, 双特异性(Antibodies, Bispecific);细胞周期(Cell Cycle);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);细胞毒性, 免疫(Cytotoxicity, Immunologic);药物协同作用(Drug Synergism);人类(Humans);K562细胞(K562 Cells);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);成束猴(Macaca fascicularis);小鼠(Mice);治疗结果(Treatment Outcome);fms样酪氨酸激酶3(fms-Like Tyrosine Kinase 3)
DOI
10.1158/1535-7163.MCT-19-1093
PMID
32518207
发布时间
2021-06-28
换一批
换一批
